Archivos de cardiologia de Mexico · 2011
[Percutaneous closure of patent ductus arteriosus using the Amplatzer vascular Plug II].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Parra-Bravo Rafael, Beirana-Palencia Luisa, Corona-Rodríguez Antonio, Alarcón-Elguera Laura, Tejeda-Hernández Norma, Aguilar-Segura Perla, Lazo-Cárdenas César, Arellano-Llamas Abril
Аннотация
UNLABELLED: The Amplatzer vascular II Plug (AVPII) is a self- expanding occluder device, indicated for arterial and venous occlusion in the peripheral circulation.
OBJECTIVE: To describe our initial clinical experience with the AVP II, in the percutaneous closure of small patent ductus arteriosus.
METHOD: We retrospectively analyzed seven patients who underwent percutaneous closure of patent ductus arteriosus. The AVP II was chosen with a diameter greater than 50% of the minimum diameter of the ductus arteriosus.
RESULTS: Patients showed a ductus arteriosus with a diameter of 1.5 ± 1.4 (range: 0.8 - 4.7 mm). Successful implant was achieved with adequate angiographic occlusion in 6 patients. One patient was sent to surgery. We only found a major complication. Transthoracic echocardiography at 24 hours, confirmed the complete occlusion in this patients. The follow-up was 10.6 ± 9.1 months.
CONCLUSION: The AVP II in this group of patients was shown to be safe and effective for percutaneous closure of patent ductus arteriosus.
OBJECTIVE: To describe our initial clinical experience with the AVP II, in the percutaneous closure of small patent ductus arteriosus.
METHOD: We retrospectively analyzed seven patients who underwent percutaneous closure of patent ductus arteriosus. The AVP II was chosen with a diameter greater than 50% of the minimum diameter of the ductus arteriosus.
RESULTS: Patients showed a ductus arteriosus with a diameter of 1.5 ± 1.4 (range: 0.8 - 4.7 mm). Successful implant was achieved with adequate angiographic occlusion in 6 patients. One patient was sent to surgery. We only found a major complication. Transthoracic echocardiography at 24 hours, confirmed the complete occlusion in this patients. The follow-up was 10.6 ± 9.1 months.
CONCLUSION: The AVP II in this group of patients was shown to be safe and effective for percutaneous closure of patent ductus arteriosus.